D. Wright

发表

Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel NaV1.7 produce distinct pain disorders

S. Dib-Hajj, S. Waxman, L. Tyrrell, 2010, Molecular pain.

The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever

M. Weisman, Bin Huang, A. Reiff, 2014, BioMed research international.

Autoimmune Lymphoproliferative Syndrome Misdiagnosed as Hemophagocytic Lymphohistiocytosis

T. Fleisher, S. Price, J. Niemela, 2013, Pediatrics.

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.

C. Wouters, P. Woo, S. Ozen, 2009, Arthritis and rheumatism.

Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever

M. Weisman, D. Kastner, Bin Huang, 2012, Annals of Internal Medicine.

Durability of nasal reconstruction in an adolescent with relapsing polychondritis treated with infliximab.

D. Wright, P. Witt, D. Bell, 2007, Plastic and reconstructive surgery.

The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1

J. Franco, T. Torgerson, R. Russell, 2015, Journal of Clinical Immunology.

Explorer The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT 1

J. Franco, T. Torgerson, R. Russell, 2015 .

The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1

J. Franco, T. Torgerson, R. Russell, 2014, Journal of Clinical Immunology.

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?

A. Parodi, P. Woo, S. Ozen, 2008, Pediatric Rheumatology Online Journal.

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.

J. Newburger, R. Sundel, D. Wright, 1996, The Journal of pediatrics.